Recent mid-stage trial data has shown promising results for the experimental cancer vaccine jointly developed by Moderna and Merck. In combination with Merck’s blockbuster therapy, Keytruda, the vaccine has demonstrated a significant reduction in the risk of death or relapse for patients with advanced melanoma, the most deadly form of skin cancer. These findings have
0 Comments
The global order is rapidly fragmenting, signaling a “new paradigm” in financial markets, according to HSBC Asset Management. This shift is accompanied by heightened recession risks, prompting an increased focus on bonds. In its 2024 investment outlook, HSBC underscores the significant risks posed by tight monetary and credit conditions, leading to a potential adverse growth
0 Comments
The Manhattan rental market, known for its sky-high prices and limited availability, is experiencing a notable shift. In November, the median rent in Manhattan fell by 2%, marking the first decline in median prices in over two years. According to a report from Douglas Elliman and Miller Samuel, the median rent dropped from $4,095 to
0 Comments
Shares of Vertex Pharmaceuticals soared on Wednesday following the release of groundbreaking results from a midstage trial of their new painkiller. This potential alternative to opioids has shown significant success in reducing pain for patients with chronic nerve conditions related to diabetes. The standout feature of this drug is its ability to provide powerful pain
0 Comments